Published in Cancer Res on December 01, 2002
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene (2007) 2.36
Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol (2013) 1.68
Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology (2009) 1.36
Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog (2009) 1.34
Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev (2012) 1.33
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A (2006) 1.31
Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J (2007) 1.27
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol (2006) 1.16
In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res (2010) 1.10
Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J Virol (2005) 1.01
Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR. BMC Biotechnol (2008) 0.93
Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol (2004) 0.93
Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer (2010) 0.93
Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol (2013) 0.89
Gene expression reveals two distinct groups of anal carcinomas with clinical implications. Br J Cancer (2008) 0.87
Integrative analyses reveal novel strategies in HPV11,-16 and -45 early infection. Sci Rep (2012) 0.82
Effective formation of the segregation-competent complex determines successful partitioning of the bovine papillomavirus genome during cell division. J Virol (2010) 0.81
A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens. Open Virol J (2012) 0.81
The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation. Viruses (2014) 0.81
Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes. J Pathol (2014) 0.80
CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression. J Virol (2015) 0.79
Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR. J Clin Microbiol (2008) 0.78
Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes. J Virol (2011) 0.78
Detection of adeno-associated virus type 2 genome in cervical carcinoma. Br J Cancer (2006) 0.77
Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci Rep (2015) 0.76
No association of oral lichen planus and hepatitis C virus infection in central Germany. Clin Oral Investig (2015) 0.75
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol (2002) 2.93
The biology and life-cycle of human papillomaviruses. Vaccine (2012) 2.53
Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res (2003) 2.29
Family medicine in 2018. Can Fam Physician (2010) 2.24
Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection. Hepatology (2008) 2.21
Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol (2005) 2.12
Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology (2005) 2.04
Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis. J Clin Virol (2005) 2.01
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol (2006) 1.69
Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer (2005) 1.64
HPV & head and neck cancer: a descriptive update. Head Neck Oncol (2009) 1.60
Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res (2010) 1.59
Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res (2004) 1.56
FUS/ERG gene fusions in Ewing's tumors. Cancer Res (2003) 1.50
Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development. Genes Dev (2006) 1.49
Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol (2005) 1.44
Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status. Liver Transpl (2010) 1.44
Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer (2005) 1.42
Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer. J Fam Plann Reprod Health Care (2004) 1.41
A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer. J Pathol (2003) 1.40
Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology (2005) 1.38
Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol (2004) 1.37
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A (2006) 1.31
Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. Clin Cancer Res (2003) 1.26
A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer (2010) 1.25
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol (2003) 1.24
Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet (2002) 1.24
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease. J Immunol (2009) 1.22
Sliding hip screw fixation of trochanteric hip fractures: outcome of 1024 procedures. Injury (2005) 1.21
Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res (2002) 1.19
Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol (2011) 1.19
Single primer amplification (SPA) of cDNA for microarray expression analysis. Nucleic Acids Res (2003) 1.18
Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res (2008) 1.17
Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol (2011) 1.17
What are wait times to see a specialist? an analysis of 26,942 referrals in southwestern Ontario. Healthc Policy (2012) 1.16
Cell-mediated immune responses to COPV early proteins. Virology (2006) 1.15
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J (2006) 1.15
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res (2003) 1.12
Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. Carcinogenesis (2006) 1.11
In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res (2010) 1.10
Translational approaches to improving cervical screening. Nat Rev Cancer (2003) 1.10
Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol (2004) 1.10
In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line. Am J Gastroenterol (2004) 1.07
Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles. J Pathol (2011) 1.07
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine (2012) 1.06
A modular approach to the ECVAM principles on test validity. Altern Lab Anim (2004) 1.04
Expression of human immunodeficiency virus (HIV)-binding lectin DC-SIGNR: Consequences for HIV infection and immunity. Hum Pathol (2002) 1.03
Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Res (2008) 1.03
High-throughput gene discovery in the rat. Genome Res (2004) 1.02
Somatic genetic changes accompanying lung tumor development. Genes Chromosomes Cancer (2005) 1.00
Improving communication between doctors and breast cancer patients. Ann Fam Med (2007) 1.00
High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer (2011) 0.97
Application and optimization of microarray technologies for human postmortem brain studies. Biol Psychiatry (2004) 0.97
The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58. Altern Lab Anim (2006) 0.97
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol Oncol (2013) 0.96
Investigation into the use of C- and N-terminal GFP fusion proteins for subcellular localization studies using reverse transfection microarrays. Comp Funct Genomics (2004) 0.96
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine (2008) 0.95
Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata. Virol J (2013) 0.95
The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer (2010) 0.94
Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology. Neuropathol Appl Neurobiol (2005) 0.94
Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR. BMC Biotechnol (2008) 0.93
Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J Virol (2004) 0.93
From genomes to vaccines: Leishmania as a model. Philos Trans R Soc Lond B Biol Sci (2002) 0.92
LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Cancer Res (2013) 0.92
A human TAPBP (TAPASIN)-related gene, TAPBP-R. Eur J Immunol (2002) 0.91
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. J Pathol (2014) 0.91
Examination of the properties of the Modified Checklist for Autism in Toddlers (M-CHAT) in a population sample. J Autism Dev Disord (2012) 0.90
Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J (2003) 0.90
Family physicians' satisfaction with current practice: what is the role of their interactions with specialists? Healthc Policy (2009) 0.89
Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol (2015) 0.89
Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF. Angiogenesis (2004) 0.88
Outcome after acute myocardial infarction: a comparison of patients seen by cardiologists and general physicians. BMC Cardiovasc Disord (2004) 0.88
Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again. J Pathol (2013) 0.88
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. Neoplasia (2005) 0.88
Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness. J Pathol (2011) 0.87
Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes. Virology (2005) 0.87
Testicular cancer: a new generation of biomarkers for malignant germ cell tumours. Nat Rev Urol (2012) 0.86
Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes. J Pathol (2005) 0.85
Sensitive HPV detection in oropharyngeal cancers. BMC Cancer (2009) 0.85
Heterogeneous inflammatory changes in liver graft recipients with normal biochemistry. Transplantation (2010) 0.84
Characteristics and practice patterns of international medical graduates: how different are they from those of Canadian-trained physicians? Can Fam Physician (2007) 0.84
Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26? Med J Aust (2008) 0.84
Cell-based microarrays: current progress, future prospects. Pharmacogenomics (2005) 0.83
Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: a pilot study. Liver Transpl (2005) 0.83
Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state. J Pathol (2013) 0.83